Skip to content

BMY vs LLY: Dividend Comparison

BMY$60.78
Bristol Myers Squibb Co
Health Care
vs
LLY$1,045.09
ELI LILLY & Co
Health Care

Dividend data as of

Bristol Myers Squibb Co (BMY) and ELI LILLY & Co (LLY) are both in the Health Care sector, making them natural rivals for dividend investors. BMY offers a significantly higher 4.09% yield compared to LLY's 0.59%, a gap of 3.51%. For dividend growth, LLY leads with a 5-year CAGR of 23.8% versus BMY's 14.0%. LLY holds the edge in dividend safety with a "Safe" rating. LLY is a Dividend Contender with 11 years of consecutive increases.

Verdict

Best for Income
BMY
Higher yield at 4.09%
Best for Growth
LLY
5yr CAGR of 23.8%
Best for Safety
LLY
Rated "Safe"
Metric
Price
$60.78
$1,045.09
Dividend Yield
4.09%
0.59%
Annual Dividend
$2.49
$6.00
5yr Div CAGR
14.0%
23.8%
3yr Div CAGR
20.4%
15.2%
Consecutive Years
0
11
Payout Ratio
71.97%
26.14%
P/E Ratio
—
—
Market Cap
—
—
Income on $10k
$409/yr
$59/yr

Yield Analysis

BMY
4.09%
LLY
0.59%

BMY yields 3.51% more than LLY. In dollar terms, BMY pays $2.49/share vs LLY's $6.00/share annually.

Dividend Growth

BMY 5yr CAGR
14.0%
accelerating
LLY 5yr CAGR
23.8%
decelerating

BMY: Dividend growth is accelerating — the 3-year CAGR of 20.4% exceeds the 5-year rate of 14.0% and the 10-year rate of 9.0%.

LLY: Dividend growth is slowing — the 3-year CAGR of 15.2% trails the 5-year rate of 23.8% and the 10-year rate of 16.4%.

Dividend Safety

BMY
Moderate
Payout Ratio72%
LLY
Safe
Payout Ratio26%

BMY: The payout ratio of 72% is moderate. The dividend is currently covered by earnings but leaves less room for growth. Earnings cover the dividend 1.4x.

LLY: The payout ratio of 26% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 3.8x.

Estimated Annual Dividend Income

Based on current dividend yields. Actual income may vary.

Investment
BMY
LLY
$10,000
$409/yr
$59/yr
$50,000
$2,046/yr
$293/yr
$100,000
$4,091/yr
$585/yr

What does $10,000 buy in BMY vs LLY today?

At $60.77 per share, $10,000 buys about 164.5 shares of Bristol Myers Squibb Co (BMY). Each share pays $2.49 per year in dividends, so the position starts out generating roughly $410 per year — about $34 a month.

At $1045.09 per share, $10,000 buys about 9.6 shares of ELI LILLY & Co (LLY). Each share pays $6.00 per year in dividends, so the position starts out generating roughly $57 per year — about $5 a month.

BMY is the larger income stream from day one: $352 per year more on the same $10,000 invested.

What could $10,000 of BMY or LLY income look like in 10 years?

Bristol Myers Squibb Co (BMY) has raised its dividend about 14.0% a year over the past five years. If that pace held, the $409 per year that $10,000 generates today at the current 4.09% yield would reach $1,513 per year by 2036 — a 15.1% yield on the original cost.

ELI LILLY & Co (LLY) has raised its dividend about 23.8% a year over the past five years. If that pace held, the $59 per year that $10,000 generates today at the current 0.59% yield would reach $497 per year by 2036 — a 5.0% yield on the original cost.

On those trailing rates, BMY pays more in 2036: $1,513 versus $497 per year. The projection assumes each five-year growth rate persists and no dividends are reinvested — real payouts will differ.

When would LLY's dividend growth overtake BMY's higher yield?

ELI LILLY & Co (LLY) yields less today (0.59% vs 4.09%) but has grown its dividend faster — 23.8% vs 14.0% a year over the past five years. If both trends continued, a $10,000 position in LLY would start out-earning the same position in BMY around 2050 (roughly 24 years from now), paying about $9,930 per year at the crossover. Before that point, BMY pays more each year; after it, the gap compounds in LLY's favor.

Can BMY and LLY afford their dividends?

Bristol Myers Squibb Co (BMY) earns $3.46 per share against $2.49 paid out in dividends — 1.4x coverage (a 72% payout ratio).

ELI LILLY & Co (LLY) earns $22.98 per share against $6.00 paid out in dividends — 3.8x coverage (a 26% payout ratio).

LLY's wider coverage leaves more cushion if earnings dip. As a rule of thumb, coverage below about 1.5x (a payout ratio above ~65%) is where a dividend starts to look stretched — worth watching for BMY if earnings weaken.

Which fits an early-retirement income portfolio better, BMY or LLY?

For income you need right now, Bristol Myers Squibb Co (BMY) leads: $100,000 invested today pays about $341 a month at the current 4.09% yield, versus $49 a month from ELI LILLY & Co (LLY) at 0.59%.

With a decade or more before the income is needed, LLY's faster dividend growth (23.8% vs 14.0% a year) matters more than the starting yield — raises compound into the larger paycheck over time.

On consistency: LLY has raised its dividend 11 consecutive years.

Many income investors simply hold both — the mix pairs current yield with growth and spreads single-name risk. Whichever way you lean, dividends are never guaranteed; recheck the payout each quarter rather than setting and forgetting.

$10,000 with DRIP: projected annual income

If each holding keeps raising its dividend at its real 5-year rate and every payment is reinvested, a $10,000 position pays $2,259/yr in BMY vs $527/yr in LLY by year 10.

Assumes dividends are reinvested at the current yield and grow at each holding's trailing 5-year dividend CAGR. A projection, not a prediction — no price appreciation modeled.

Track BMY and LLY in your portfolio

See your real income from both — forward projections, yield on cost, and dividend safety signals. Sync your brokerage free for 30 days, or track holdings manually on the free plan.

Choosing a tracker? See the best dividend trackers compared.

Frequently Asked Questions

This tool is for educational and informational purposes only and does not constitute investment, financial, tax, or legal advice. Consult a licensed professional before making investment decisions.

Past performance does not guarantee future results. All projections are hypothetical estimates based on user-provided inputs and may differ materially from actual outcomes.

By using this tool you agree to our Terms of Service and Privacy Policy.